HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease.

Abstract
Diagnosis of invasive fungal disease (IFD) in patients under intensive care is challenging. Circulating biomarkers, (1,3)-β-D-glucan (BG) and galactomannan (GM), were prospectively assessed in 98 critically ill patients at risk of IFD. There were 11 cases of invasive aspergillosis (IA; 4 proven and 7 probable), 9 cases of proven invasive candidiasis (IC), 1 case of mixed proven IC and probable IA, 1 case of proven zygomycosis, and 1 case of mixed mycelial proven IFD. In all IA cases there was no significant difference when the area under the receiver operating characteristic curve (AUC) of GM (0.873 [95%CI, 0.75-0.99]) and BG (0.856 [95% CI, 0.71-0.99]) were compared (p = 0.871). The AUC for BG in IC and for the rest of the IFD cases was 0.605 (95% CI, 0.39-0.82) and 0.768 (95% CI, 0.63-0.90) respectively. Positive BG (40%) predated blood culture (n = 3) and abdominal pus (n = 1) a mean of 3.25 days before Candida was grown. In patients with IFD caused by molds, BG appeared a mean of 5.65 days before culture results. For the diagnosis of patients at risk of IC, BG has shown a high NPV (94.5%), with positive results also predating blood cultures in 30% of patients. In conclusion, early BG results permit a timely initiation of antifungal therapy in patients at risk of IFD.
AuthorsJ Acosta, M Catalan, A del Palacio-Pérez-Medel, J-C Montejo, J De-La-Cruz-Bértolo, M-D Moragues, J Pontón, M A Finkelman, A del Palacio
JournalEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (Eur J Clin Microbiol Infect Dis) Vol. 31 Issue 5 Pg. 721-31 (May 2012) ISSN: 1435-4373 [Electronic] Germany
PMID21811868 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Mannans
  • Proteoglycans
  • beta-Glucans
  • galactomannan
  • polysaccharide-K
  • Galactose
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Critical Illness
  • Female
  • Galactose (analogs & derivatives)
  • Humans
  • Male
  • Mannans (blood)
  • Middle Aged
  • Mycoses (diagnosis)
  • Prospective Studies
  • Proteoglycans
  • ROC Curve
  • Sepsis (diagnosis, microbiology)
  • beta-Glucans (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: